SNCA and depressive symptom measurement: In summary, our findings reveal a significantly elevated peripheral gene expression of SNCA, GBA1, and UGCG among patients currently experiencing depression which partially normalizes for GBA1 and UGCG in the group of medicated patients and also reflects increased depression severity in subgroups.